Advances in the Treatment of Malignant Melanoma

EP. 1: Optimal Management of Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 2: Identifying Patients for Neoadjuvant Melanoma Therapy

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 3: Molecular Testing in Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 4: pCR and Neoadjuvant Therapy for Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 5: Neoadjuvant Data Explored for Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 6: Adjuvant Data Explored for Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 7: Adjuvant Therapy for Melanoma: Ongoing Studies of Interest

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 8: Adjuvant Therapy for Melanoma: Safety and Efficacy

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 9: Systemic Therapy for Metastatic Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 10: Novel Therapies for Metastatic Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 11: I/O Dosing Schedules in Metastatic Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 12: Management of Brain Metastases in Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 13: Novel Approaches for Relapsed/Refractory Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 14: Targeted Therapy Versus IO for Relapsed/Refractory Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 15: Promising Late-Stage Trials in Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 16: Future Treatment Landscape for Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 17: Treatment Optimization for Patients With Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 1: Optimal Management of Locally Advanced Melanoma

EP. 2: Identifying Patients for Neoadjuvant Melanoma Therapy

EP. 3: Molecular Testing in Locally Advanced Melanoma

EP. 4: pCR and Neoadjuvant Therapy for Melanoma

EP. 5: Neoadjuvant Data Explored for Locally Advanced Melanoma

EP. 6: Adjuvant Data Explored for Locally Advanced Melanoma

EP. 7: Adjuvant Therapy for Melanoma: Ongoing Studies of Interest

EP. 8: Adjuvant Therapy for Melanoma: Safety and Efficacy

EP. 9: Systemic Therapy for Metastatic Melanoma

EP. 10: Novel Therapies for Metastatic Melanoma

EP. 11: I/O Dosing Schedules in Metastatic Melanoma

EP. 12: Management of Brain Metastases in Melanoma

EP. 13: Novel Approaches for Relapsed/Refractory Melanoma

EP. 14: Targeted Therapy Versus IO for Relapsed/Refractory Melanoma

EP. 15: Promising Late-Stage Trials in Melanoma

EP. 16: Future Treatment Landscape for Melanoma

EP. 17: Treatment Optimization for Patients With Melanoma

Trending on OncLive

FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

FDA Awards Traditional Approval to Selpercatinib for RET+ Advanced Solid Tumors

Research Rewind: Phase 3 Breast Cancer Data Highlights From Q2 2026

FDA Grants Fast Track Designation to SOT109 in Advanced Colorectal Cancer

Phosphorus-32 Plus FOLFIRINOX Meets Primary End Points in Locally Advanced Pancreatic Cancer